Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

SHOCKING: 4 | Mind Blowing Facts

This Cannabis MSO Is Well-Placed To Benefit From NJ Rec Market Launch, Analyst Thoughts Ahead Q1 Earnings

Green Thumb Industries (CSE: GTII) (OTC: GTBIF) is scheduled to report its first-quarter earnings report on Wednesday.

Benzinga

This Analyst Has Mixed Feelings About Tilray's Promise To Achieve $4B In Revenue By 2024, Here's Why

Tilray Brands' (NASDAQ: TLRY) stock has plunged nearly 30% year-to-date.

Benzinga

This Cannabis Retailer Is Poised To Grow Top-Line Despite Tough Environment, Analyst Explains Why

Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF) reported its financial and operational results for the fiscal year and fourth quarter ended January 29, 2022.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

What To Focus On Now After Tilray's Q3 Earnings Report, Analyst Shares Main Takeaways

On Wednesday, Tilray Brands, Inc. (NASDAQ:TLRY) reported financial results for the third fiscal quarter ended Feb. 28, 2022, with net revenue up 23% from the same quarter last year, reaching $152 million.

Benzinga

Cantor Fitzgerald Lowers Price Target On Trulieve Post Earnings, Here's Why

Trulieve Cannabis Corp.

Benzinga

Jushi's Earnings Power Is Evolving But This Analyst Remains Sidelined, At Least For Now

Jushi Holdings Inc. (OTC: JUSHF) reported its financial results for the fourth quarter and full-year ended December 31 last week, revealing a 159% year-over-year increase in revenue to $209.3 million in 2021.

Benzinga

Why Is Trulieve Still Among Top Cannabis Stock Picks? Analyst's Thoughts Ahead Of Q4 Earnings

Trulieve Cannabis Corp. (OTC: TCNNF) (OTC: TRUL) is scheduled to report its financial results for the fourth quarter of 2021 and issue guidance for 2022 on Wednesday, March 30.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Analyst on Charlotte's Web: 'We Stay Neutral, But Do Keep An Eye On This CBD Sector Bellwether Stock'

The Analyst

Benzinga

Federal Cannabis Legalization: Are The Stars Aligning? Will The Dems And GOP Meet In The Middle?

Cannabis stocks went into a tizzy, in a good way, on Thursday’s blockbuster news that the House of Representatives will call a vote next week on the MORE Act - Marijuana

Benzinga

When Will New Jersey's Marijuana Sales Begin? What's Next After Yet Another Delay?

Curaleaf Holdings' (OTC:CURLF) founder and chairman Boris Jordan was one of many disappointed cannabis entrepreneurs who did not take the news well.

Benzinga

Analyst On Cresco's Deal With Columbia Care And Earnings Results For Q4 2021

The Analyst: Pablo Zuanic, from Cantor Fitzgerald, rated Cresco Labs, Inc. (OTC: CRLBF) as Overweight with a price target of $19.00.

Benzinga

From Pharmacist To Successful Cannabis Exec, Jason Wild Of TerrAscend: Meet Our Keynote Speakers

It is well known that a career is a lifelong journey that can take many turns. Today we’re taking a look at an inspiring story of a pharmacist who ended up managing a fund focused on cannabis and healthcare.

Benzinga

What Are Upside Catalysts For HEXO Stock? Analyst Thoughts Post Q2 Earnings

On Friday, cannabis company HEXO Corp. (NASDAQ: HEXO) reported a staggering loss of CA$690.2 million ($546,94 million) for the second quarter of fiscal 2022, compared to CA$20

Benzinga

Analyst Is Warming Up To This Cannabis Stock As It Reports Q1 Earnings & Successful Shift To Discount Model

On Thursday, Canadian cannabis retailer High Tide Inc.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Is Village Farms Positioned For Business Growth Despite Revenue Drop? Analyst Opines Post Q4 Earnings

Village Farms International, Inc.

Benzinga

What Does Tilray Get From HEXO Debt Deal? Analyst Says 'Chapeau!' To CEO Irwin Simon

On Thursday, HEXO Corp. (NASDAQ: HEXO) finalized a strategic partnership with Tilray Brands, Inc.

Benzinga

Brief Thoughts Ahead Of 4Q For Curaleaf Holdings: New Jersey Could Be Next Main Catalyst

The Analyst Pablo Zuanic, from Cantor Fitzgerald, kept Curaleaf among the firm’s top picks in the MSO group, with an Overweight rating and a price target at US$16.50. The Thesis

Benzinga

Green Thumb Industries Among Top Cannabis MSO Stocks Ahead Of Earnings Season, Analyst Tells Us Why

As earnings season approaches, Cantor Fitzgerald analyst Pablo Zuanic discussed his expectations. One of his top stock picks, Green Thumb Industries Inc.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Analyst: Dissecting Marijuana Sales Growth And Cannabis Dispensary Performance in Florida

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald takes a close look at Florida's operators regarding store trends and total sales growth. The Florida medical marijuana market has continued to slow in the first quarter of 2022, after mid-teens sequential growth earlier in 2021.

Benzinga

The Week In Cannabis: Schumer's Bill, The Super Bowl, Leafly, Canopy Growth, Tilray, Hexo, Sundial And More

Below is a recap of the main news related to the cannabis industry and markets for the week of February 7, 2022. Contents

Benzinga

Will Aurora Bounce Back? Analyst Explains Why The Stock Is A 'Long-Term Turnaround Story'

Aurora Cannabis (NASDAQ: ACB) (TSX:ACB) released its

Benzinga

Canopy Growth Shares Are Trading Higher Today, Analysts Tell Us Why

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) reported its financial results Wednesday for the third quarter fiscal 2022 ended December 31, 2021, reve

Benzinga

What's In It For Verano? Analyst Thoughts On $413M Goodness Growth Acquisition

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) and Goodness Growth Holdings, Inc.

Benzinga

Will Constellation Brands Use Canopy Growth Stock Drop To Acquire Higher Stake? Analyst Thoughts

Since the beginning of the year, Canopy Growth (NASDAQ: CGC) shares dropped 28.05% to $6.85 per share.

Benzinga

Cannabis Analyst Advises Not To Buy WeedMaps Shares Until March

Cantor Fitzgerald has issued a new report on cannabis tech platform WeedMaps (NASDAQ: MAPS), also known as WM Technology Inc.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

House of Representatives

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.